Pregnancy claims
This article was originally published in The Tan Sheet
Executive Summary
Amendment of the structure/function claims final rule to prohibit statements concerning edema associated with pregnancy is requested by CHPA in a citizen petition filed with FDA May 11. The trade group asks the agency to issue a regulation requiring label statements on certain dietary supplements pertaining to their use by women who are pregnant or nursing, and calls on CFSAN to develop a guidance on the "scientific basis for assessing the potential for possible effects of dietary supplements on reproduction/development and the scope and nature of safety-related evidence that is needed to support a structure/function claim for conditions associated with pregnancy and nursing." CHPA suggests FDA use the association's voluntary pregnancy/nursing labeling program, announced in March, as a basis for creating a regulatory framework (1"The Tan Sheet" March 27, p. 3)